Who Owns ScripsAmerica, Inc. Company?

ScripsAmerica, Inc. Bundle

Get Full Bundle:

	SWOT	$15	$10
	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10

TOTAL:

ADD TO CART

Who Really Controlled ScripsAmerica, Inc.?

Understanding a company's ownership structure is crucial for investors and analysts alike. It reveals the driving forces behind strategic decisions and financial performance. This is especially true when a company faces significant challenges, such as bankruptcy. This analysis uncovers the ScripsAmerica, Inc. SWOT Analysis and its ownership journey.

The story of ScripsAmerica, Inc. and its ownership is a tale of ambition, expansion, and ultimately, financial distress. Before delving deeper, it's important to understand the company's core business and its subsidiaries. This exploration will provide valuable insights into the company's corporate structure, the impact of its bankruptcy, and the key players involved in ScripsAmerica ownership. Knowing the ScripsAmerica owner is key.

The history of ScripsAmerica, Inc. begins with its co-founder, Robert Schneiderman, who played a pivotal role in shaping the company's trajectory. As CEO and President, Schneiderman's leadership was instrumental in guiding ScripsAmerica from its early stages as a privately held entity to its evolution into a publicly traded corporation.

While the precise initial equity distribution among the founders isn't fully detailed in available records, Schneiderman's prominent role as a co-founder and leader underscores his significant early stake and influence within the company. Understanding the initial ownership structure provides crucial context for analyzing the company's subsequent financial activities and corporate structure.

Early financial transactions significantly influenced ScripsAmerica ownership. In March 2011, the Board of Directors approved the issuance of 2,990,252 shares of Series A Preferred Stock through a private placement, which generated approximately $1,043,000. These preferred shares provided an annual dividend of 8% of the original purchase price and held priority in the distribution of cash and assets.

Early Investors

Development 72, LLC, was a key early investor in ScripsAmerica. As of August 16, 2012, they held 2,990,252 shares of Series A Preferred Stock.

Preferred Stock Details

These preferred shares were convertible into 5,980,504 shares of common stock. This represented about 10.6% of the outstanding shares at the time.

Additional Investment

Development 72, LLC also provided a $500,001 loan to the company in August 2012.

Implex Corporation's Role

Implex Corporation, owned by ScripsAmerica's legal counsel, was involved in the company's operations. This relationship highlights the influence of legal counsel on the company's early business activities.

Acquisition of Main Avenue Pharmacy

In January 2014, Implex Corporation entered into a stock purchase agreement to acquire Main Avenue Pharmacy. By October 2014, Implex transferred its ownership interest in Main Avenue to ScripsAmerica.

100% Ownership

This transfer gave ScripsAmerica full, or 100%, ownership of Main Avenue Pharmacy.

The early history of ScripsAmerica, including its ownership structure and key financial agreements, provides essential context for understanding the Brief History of ScripsAmerica, Inc. and its evolution as a pharmacy benefit manager. These details are crucial for anyone researching ScripsAmerica ownership or seeking company information, including potential investors and those interested in the corporate structure.

ScripsAmerica, Inc. SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The ownership of ScripsAmerica, Inc. underwent significant changes, especially as the company faced financial difficulties. As a publicly traded entity, ScripsAmerica's corporate structure included an authorized share count of 250,000,000 shares with a par value of $0.001 per share. Each share entitled its holder to one vote. By January 22, 2016, there were 139,097,969 shares of Common Stock and 2,990,252 shares of Series A Preferred Stock outstanding. The evolution of ScripsAmerica ownership is crucial for understanding its financial journey.

A key player in the ScripsAmerica ownership structure was Ironridge Global Partners, LLC. Ironridge Global IV, Ltd. was involved in litigation with the company. In February 2014, ScripsAmerica issued 1,615,550 shares of common stock to Ironridge. By April 2014, Ironridge sought an additional 1,646,008 common shares, which ScripsAmerica declined. The company stated that Ironridge had already received approximately 10,305,550 common shares with a market value of roughly $1,300,000 in satisfaction of $766,238. This shows Ironridge's significant stake and its active role in the company's financial dealings. Understanding the ScripsAmerica owner is vital.

ScripsAmerica's subsidiaries also played a role in its ownership structure. Main Avenue Pharmacy Inc., DispenseDoc Inc., and Pharmacy Administration, Inc. were wholly owned. P.I.M.D. International LLC was 90% owned by ScripsAmerica. Main Avenue Pharmacy, for example, accounted for about 97% of ScripsAmerica's net revenues in 2014. The company's financial struggles led to a Chapter 11 bankruptcy filing on September 7, 2016, later converted to Chapter 7 on February 8, 2017. This conversion resulted in the appointment of a trustee to liquidate assets, effectively dissolving the existing ownership. The company's journey is detailed in Revenue Streams & Business Model of ScripsAmerica, Inc.

Key Takeaways on ScripsAmerica Ownership

The ownership of ScripsAmerica was shaped by institutional investors and its subsidiaries. The company's bankruptcy proceedings significantly impacted its ownership structure.

• Ironridge Global Partners, LLC was a major stakeholder.
• Subsidiaries like Main Avenue Pharmacy Inc. were crucial to operations.
• Chapter 7 bankruptcy led to the liquidation of assets.
• Understanding the ScripsAmerica owner is crucial.

ScripsAmerica, Inc. PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Before its Chapter 7 conversion, the Board of Directors of ScripsAmerica, Inc. played a critical role in governance. Brian Ettinger served as Chairman of the Board and Interim CEO as of July 7, 2015, with Adam Brosius named Interim President. Robert Schneiderman, a co-founder, resigned as President, CEO, and Board member on July 1, 2015. For those seeking information about the company, understanding the ScripsAmerica ownership structure is key.

In October 2012, the Board saw changes with the addition of four new directors: Dorrit M. Bern, Lynda J. Davey, Mindy C. Meads, and John S. Mills. Lynda J. Davey was appointed Chairman of the Board at that time. These new directors filled vacancies left by the resignations of Harold D. Kahn, Jonathan Duskin, Sidney M. Horn, and Henry D. Winterstern. Continuing members included Kathy Bronstein, John D. Goodman, and Kenneth M. Reiss. Kenneth M. Reiss continued to serve as the chairman of the Audit Committee. Understanding the company information is crucial for investors.

The voting structure for ScripsAmerica's common stock was generally one-share-one-vote. However, Series A Preferred Stock carried specific voting rights, including the ability to elect one director and veto power over certain corporate matters. This gave preferred shareholders, such as Development 72, LLC, a significant degree of control. The governance controversies surrounding the company's bankruptcy, including the appointment of an official committee of unsecured creditors, highlight the contentious environment during its final years. For more insights into the company's history, you can refer to articles like the one on [ScripsAmerica, Inc.](0).

Governance and Control

The Board of Directors oversaw the operations of ScripsAmerica. The voting rights were structured to give preferred shareholders significant influence. The company's financial distress led to changes in leadership and governance.

• Chairman of the Board and Interim CEO: Brian Ettinger.
• Interim President: Adam Brosius.
• Preferred Stock Voting Rights: Included veto power over key corporate decisions.
• Unsecured Creditors Committee: Appointed during Chapter 11 proceedings.

ScripsAmerica, Inc. Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Recent developments for ScripsAmerica are centered on its Chapter 7 bankruptcy conversion, which occurred on February 8, 2017. This action led to the liquidation of its assets. As of June 2025, the company is listed as 'Out of Business,' with a market capitalization of approximately $1.41 thousand. This status effectively dissolved the previous ScripsAmerica ownership structure, including shareholders.

Prior to the Chapter 7 conversion, attempts were made at asset sales and acquisitions. In 2014, the company acquired Main Avenue Pharmacy Inc. and a majority stake in P.I.M.D. International LLC. However, subsequent deals, such as the acquisition of PIMD International LLC by AEM Medical Group LLC and the acquisition of Pharmacy Administration, Inc. by Jaysukh Sabhaya, were canceled. These cancellations highlight the challenges in divesting assets during the company's restructuring phase. For more information on the company's strategic moves, you can read the Growth Strategy of ScripsAmerica, Inc..

The broader industry, including pharmacy benefit manager services, is characterized by increased institutional ownership and consolidation. However, given ScripsAmerica's current state of liquidation, these trends are not directly applicable. The focus is now on the bankruptcy process, managed by the Chapter 7 Trustee, Charles Stanziale, Jr., who was appointed on February 9, 2017. Legal proceedings, such as breach of fiduciary duty actions, have been settled. Public statements about future ownership changes are irrelevant. The company's "Out of Business" status means there are no ongoing ownership trends in the traditional sense, only the final stages of asset disposition under bankruptcy law.

Key Events

Chapter 7 Bankruptcy Conversion: February 8, 2017. Liquidation of assets initiated. Market Capitalization: Approximately $1.41 thousand as of June 2025. Asset Sales and Acquisitions: Attempts to restructure, including acquisitions of Main Avenue Pharmacy Inc. and a majority stake in P.I.M.D. International LLC.

Ownership Status

Dissolution of Ownership: Previous ownership structure dissolved due to bankruptcy. Chapter 7 Trustee: Charles Stanziale, Jr., manages remaining assets and liabilities. Legal Proceedings: Breach of fiduciary duty actions settled. Future Trends: No ongoing ownership trends in the traditional sense.

ScripsAmerica, Inc. Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Related Blogs